Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency

Published:2021-12 Issue: Volume:225 Page:113790
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Yingge,Sun Moran,Wang Yuyang,Qin Jinling,Zhang Yixin,Pang Yingyue,Yao Yongfang,Yang Hua,Duan Yongtao

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference33 articles.

1. Precision tumor medicine and drug targets;Liu;Curr. Top. Med. Chem.,2019

2. Drug combination in clinical cancer treatments;Lu;Rev. Recent Clin. Trials,2017

3. Hybrid molecules: the privileged scaffolds for various pharmaceuticals;Shaveta;Eur. J. Med. Chem.,2016

4. Anticancer triazenes: from bioprecursors to hybrid molecules;Francisco;Curr. Pharmaceut. Des.,2019

5. Antiangiogenic therapy: challenges and future directions;Su;Curr. Top. Med. Chem.,2021

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis;Genes & Diseases;2024-11

2. Discovery of novel amide derivatives against VEGFR-2/tubulin with potent antitumor and antiangiogenic activity;Bioorganic Chemistry;2024-10

3. Dual-target inhibitors of colchicine binding site for cancer treatment;European Journal of Medicinal Chemistry;2024-08

4. Design and biological evaluation of dual tubulin/HDAC inhibitors based on millepachine for treatment of prostate cancer;European Journal of Medicinal Chemistry;2024-03

5. Design, synthesis and biological evaluation of novel imidazole-based benzamide and hydroxamic acid derivatives as potent histone deacetylase inhibitors and anticancer agents;Journal of Molecular Structure;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3